A Comparative Effectiveness Study Between Two Methods of Reconstruction of Pelvic Floor After Rectal Excision in Advanced Rectal Cancer (NEAPE)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The trial compares two different techniques for reconstruction of the lesser pelvic floor after an extended abdominoperineal excision for locally advanced rectal cancer. The alternative reconstruction techniques in the trial are:
- a technique using a gluteus maximus myocutaneous flap or
- a technique using an acellular porcine collagen implant
The primary endpoint will be physical performance six months from operation and our hypothesis is that the technique using an acellular porcine implant will cause less impaired physical performance compared to the technique using a myocutaneous flap.
The study is interventional, randomized and by definition a comparative effectiveness research project.
| Condition | Intervention | Phase |
|---|---|---|
|
Rectal Cancer Defect of Floor of Lesser Pelvis |
Procedure: Reconstruction of floor of lesser pelvis with an acellular porcine collagen implant Procedure: Reconstruction of floor of lesser pelvis with a gluteus maximus flap |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Nordic Extended Abdominoperineal Excision (NEAPE) Study, a Randomized Clinical Trial Comparing a Collagen Implant With a Gluteus Maximus Flap for Reconstruction of Pelvic Floor After Extended Abdominoperineal Excision of Rectum in Rectal Cancer |
- Performance in Timed-Stands Test [ Time Frame: 6 months after surgery ] [ Designated as safety issue: No ]Timed-Stands test is a combined measure of physical performance depending on at least muscle strength, balance, tenderness of gluteal skin and muscles and co-ordination of motion.
- Change in physical performance [ Time Frame: 3, 6 and 12 months after surgery compared with preoperative results ] [ Designated as safety issue: No ]Change in Timed-Stands Test performance
- Primary wound healing assessed with the Southampton Wound Assessment Scale [ Time Frame: 3 months from operation ] [ Designated as safety issue: No ]The Southampton Wound Assessment Scale is a validated measure of wound healing after surgery.
- Complications according to classification by Dindo-Clavien [ Time Frame: 3, 6 and 12 months after surgery ] [ Designated as safety issue: Yes ]The Dindo-Clavien classification of surgical complications is a validated instrument.
- Proportion of persistent perineal sinus or fistula [ Time Frame: 3, 6 and 12 months after surgery ] [ Designated as safety issue: No ]Proportion of patients with the wound healing defect of all patients in the particular study arm
- Ability to sit [ Time Frame: 3, 6 and 12 months after surgery ] [ Designated as safety issue: No ]Ability to sit is graded with a scale in three degrees.
- Change of pain and discomfort in gluteal region measured with VAS [ Time Frame: 3, 6 and 12 months after surgery compared to preoperative ] [ Designated as safety issue: No ]A standard visual analogue scale (VAS) from 0-100 mm is used.
- Change of quality of life measured with EQ-5D and EORTC forms C30 and CR29 [ Time Frame: 3, 6 and 12 months after surgery compared to preoperative ] [ Designated as safety issue: No ]EQ-5D and EORTC are validated quality of life instruments
- Quality of life spot measures [ Time Frame: 3, 6 and 12 months after surgery ] [ Designated as safety issue: No ]Quality of life at specified time points
- Length of hospital stay, costs of surgical treatments and QALYs gained [ Time Frame: one year after surgery ] [ Designated as safety issue: No ]Quality adjusted life year (QALY) is calculated using an quality of life utility index at repeated time points. The utility index is adjusted for the relevant background population.
| Estimated Enrollment: | 108 |
| Study Start Date: | May 2011 |
| Estimated Study Completion Date: | May 2016 |
| Estimated Primary Completion Date: | November 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Porcine collagen implant
Patients who have the floor of lesser pelvis reconstructed with an acellular porcine collagen implant.
|
Procedure: Reconstruction of floor of lesser pelvis with an acellular porcine collagen implant
Reconstruction of floor of lesser pelvis with an acellular porcine collagen implant after extended excision of rectum including levator muscles in advanced low rectal cancer.
|
|
Active Comparator: Gluteus maximus flap
Patients who have the floor of lesser pelvis reconstructed with a gluteus maximus myocutaneous flap.
|
Procedure: Reconstruction of floor of lesser pelvis with a gluteus maximus flap
Reconstruction of floor of lesser pelvis with an gluteus maximus myocutaneous flap after extended excision of rectum including levator muscles in advanced low rectal cancer.
|
Detailed Description:
Extended abdominoperineal excision (EAPE) of the rectum is the potentially curative operation for rectal carcinomas too low for primary anastomosis, especially if the levator and sphincter musculature is infiltrated. This enlarged operation, when the levator musculature is excised en bloc with the rectum, creates a large defect. Primary closure is often not possible, and reconstruction with prosthetic material or a myocutaneous flap is necessary to avoid a perineal hernia. Implantation of a collagen sheet has shown preliminary good results and on the other hand, the use of a gluteus myocutaneous flap is routine in many clinics. There is a lack of scientific evidence to prove which method is better for the reconstruction of the lesser pelvic floor.
The current study aims to compare the two reconstruction techniques.
Centres that treat locally advanced rectal cancers with the extended abdominoperineal excision of rectum (EAPE)[Holm et al 2007] can participate provided that:
- the operative technique is standardized according to the study protocol
- the centre/unit has resources for examinations of participants by a physiotherapist or a nurse
- the centre/unit has one investigator in charge of the study locally
- the centre/unit has an operative volume that enables at least 6 patients to be included/randomised during the anticipated three year study phase for inclusions
Centres that do not operate the rectal cancers included in this study can participate by arranging the preoperative examination and physical tests as well as follow-up of patients that are referred to other centres for the operation. In these cases the operating centre cares for the randomisation, operation and start of postoperative rehabilitation while the study follow-up and final rehabilitation can be completed at the patients' primary referral hospital. The primary referral hospital needs a site investigator in charge of study patients just like centres that do the operations.
Patients with primary or recurrent cancers of rectal origin can be included but individual patients can be included only once. Concomitant therapies are allowed and preoperative or postoperative radiation therapy and/or chemotherapy may be given or not according to local multidisciplinary team (MDT) decisions.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult (18 years or older) rectal cancer patients where wide resection of pelvic floor muscles together with rectum and anal canal have made reconstruction of pelvic floor necessary i.e. primary suture of pelvic floor in the midline is not possible. Resection of coccyx is optional.
Exclusion Criteria:
- Age less than 18 years
- Very large resections including partial resection of sacrum and patients considered for bilateral flap reconstruction
- Large concomitant resection of vaginal wall where total (vaginal) wound closure is not an option
- Expected survival less than one year at operation
- Patient do not sign informed consent document
Contacts and Locations| Contact: Kerstin M Granberg, B.Sc. | +46-90-7858039 | kerstin.m.granberg@vll.se |
| Contact: Markku M Haapamäki, MD, PhD | +46-90-7852013 | markku.haapamaki@surgery.umu.se |
| Sweden | |
| Sunderby County Hospital | Recruiting |
| Luleå, Sweden, 971 80 | |
| Contact: Michael Dahlberg, MD, PhD +46-920 282000 michael.dahlberg@nll.se | |
| Principal Investigator: Michael Dahlberg, MD, PhD | |
| Karolinska University Hospital, Solna | Recruiting |
| Stockholm, Sweden, 171 76 | |
| Contact: Anna Martling, MD, PhD +46-8-51772802 anna.martling@karolinska.se | |
| Principal Investigator: Anna Martling, MD, PhD | |
| Umeå University Hospital | Recruiting |
| Umeå, Sweden, 901 85 | |
| Contact: Kerstin M Granberg, B.Sc. +46-90-785 8039 kerstin.m.granberg@vll.se | |
| Contact: Markku M Haapamäki, MD, PhD +46-90-7852013 markku.haapamaki@surgery.umu.se | |
| Principal Investigator: Markku M Haapamäki, MD, PhD | |
| Sub-Investigator: Jesper Näsström, MD | |
| Uppsala University Hospital | Recruiting |
| Uppsala, Sweden, 751 85 | |
| Contact: Lars Påhlman, MD, PhD +46-18-6110000 lars.pahlman@surgsci.uu.se | |
| Principal Investigator: Lars Påhlman, MD, PhD | |
| Östersund Hospital | Recruiting |
| Östersund, Sweden, 831 83 | |
| Contact: Pär Nordin, MD, PhD +46-63-153000 par.nordin@jll.se | |
| Principal Investigator: Pär Nordin, MD, PhD | |
| Principal Investigator: | Markku M Haapamäki, MD, PhD | Umeå University |
| Study Chair: | Peter Naredi, MD, PhD | Umeå University |
| Study Director: | Jörgen Rutegård, MD, PhD | Umeå University |
More Information
Publications:
| Responsible Party: | Torbjörn Myrnäs, Head of Department, Department of Surgery, Umeå University Hospital, County Council of Västerbotten |
| ClinicalTrials.gov Identifier: | NCT01347697 History of Changes |
| Other Study ID Numbers: | NEAPE-2010-335-31M |
| Study First Received: | May 3, 2011 |
| Last Updated: | May 3, 2011 |
| Health Authority: | Sweden: The National Board of Health and Welfare |
Keywords provided by Umeå University:
|
rectal neoplasms reconstructive surgical procedure bioprosthesis |
surgical flaps locomotion lesser pelvis |
Additional relevant MeSH terms:
|
Rectal Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013